EG27140A - Preparation and characterization of metformin as insulin resistant reducing agents for type ii diabetes - Google Patents
Preparation and characterization of metformin as insulin resistant reducing agents for type ii diabetesInfo
- Publication number
- EG27140A EG27140A EG2010071268A EG2010071268A EG27140A EG 27140 A EG27140 A EG 27140A EG 2010071268 A EG2010071268 A EG 2010071268A EG 2010071268 A EG2010071268 A EG 2010071268A EG 27140 A EG27140 A EG 27140A
- Authority
- EG
- Egypt
- Prior art keywords
- metformin
- diabetes
- characterization
- preparation
- type
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 238000012512 characterization method Methods 0.000 title 1
- 239000003638 chemical reducing agent Substances 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 title 1
- 229960003105 metformin Drugs 0.000 title 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EG2010071268A EG27140A (en) | 2010-07-28 | 2010-07-28 | Preparation and characterization of metformin as insulin resistant reducing agents for type ii diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EG2010071268A EG27140A (en) | 2010-07-28 | 2010-07-28 | Preparation and characterization of metformin as insulin resistant reducing agents for type ii diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EG27140A true EG27140A (en) | 2015-08-09 |
Family
ID=54696259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EG2010071268A EG27140A (en) | 2010-07-28 | 2010-07-28 | Preparation and characterization of metformin as insulin resistant reducing agents for type ii diabetes |
Country Status (1)
| Country | Link |
|---|---|
| EG (1) | EG27140A (en) |
-
2010
- 2010-07-28 EG EG2010071268A patent/EG27140A/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2707017T3 (en) | Lixisenatide and metformin for treatment of diabetes type 2 | |
| EP2718317A4 (en) | Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof | |
| IL220889A0 (en) | Methods of treating diabetes with dll4 antagonists | |
| IL222778A0 (en) | Diabetes therapy | |
| EP2615109A4 (en) | Localized pegylated modifications of exendin-4 analogs and use thereof | |
| AP2013006816A0 (en) | Ptocess for preparing pan-CDK inhibitors of the formula (I), and intermediates in the preparation | |
| PT2691109E (en) | Prevention of hypoglycaemia in diabetes mellitus type 2 patients | |
| IL223289A0 (en) | Treatment of type 2 diabetes | |
| IL215245A0 (en) | Use of nkp46 for preventing diabetes | |
| HUE038787T2 (en) | Tripeptide compositions and their use for treatment of diabetes | |
| ZA201301936B (en) | Methods and compositions for treatment of diabetes and dyslipidemia | |
| EP2563768A4 (en) | Preparation of febuxostat | |
| ZA201003844B (en) | Delivery of functional compounds | |
| ZA201306905B (en) | Novel octahydrothienoquinonline derivative,pharmaceutical composition comprising derivative, and use of these | |
| ZA201007911B (en) | Processes for refolding of insulin | |
| EP2402342A4 (en) | Pharmaceutical composition for treatment of 2 type diabetes | |
| ZA201404738B (en) | Treatment of type i and type ii diabetes | |
| EG27140A (en) | Preparation and characterization of metformin as insulin resistant reducing agents for type ii diabetes | |
| GB0919603D0 (en) | Use of thymosin beta-4 for treatment of type II diabetes | |
| SI2399583T1 (en) | Use of vaginally-administered insulin sensitizing agents | |
| TWM401071U (en) | Improved structure of safety hook (I) | |
| HU1000688D0 (en) | Use of trifluoro-phal | |
| GB201018482D0 (en) | Crystal structure of isoglutaminyl cyclase | |
| TWM385777U (en) | Modified structure for dual purpose of indication and insect-catching frame | |
| AU2010902914A0 (en) | Treatment of diabetes |